Your Annual Touchpoint with the Global RNA-Targeted Industry to Foster New & Existing Relationships
The RNA-targeting small molecule field is rapidly evolving, with drug developers racing to progress best-in-class molecules across splice modulation, direct RNA binding, RNA degradation, covalent chemistry, epitranscriptomic regulation, condensate biology and induced-proximity approaches. To accelerate programs from discovery toward the clinic, leading teams are looking for specialist partners who can strengthen RNA target understanding, improve selectivity, support compound optimization and de-risk preclinical development.
The 9th RNA-Targeted Drug Discovery & Development Summit is returning to Boston as your opportunity to meet and network with decision-makers from RNA-targeting biopharma, including experts from PTC Therapeutics, Remix Therapeutics, ReviR Therapeutics, AstraZeneca, Sanofi, Arrakis Therapeutics, Syrna Therapeutics, Dewpoint Therapeutics, Ribonaut Therapeutics, Ribometrix and more, maximizing your opportunity to generate revenue and build long-lasting connections.
Position your brand as a trusted partner in this rapidly advancing field and build lasting relationships with the RNA-targeted small molecule community by registering your interest for 2026.
Meeting New Clients Expand your client base within the RNA-targeted small molecule community by networking face-to-face with pharma, biotech and academic leaders actively seeking solutions to strengthen target discovery, screening, selectivity and candidate progression.
Centering Yourself in Biopharma Dealmaking Position your brand in front of senior decision-makers by showcasing your company logo across event materials including the website, brochure, event guide and on-site signage.
What to Expect?
Meet New Clients
Expand your client base within the RNA-targeted small molecule community by networking face-to-face with pharma, biotech and academic leaders actively seeking solutions to strengthen target discovery, screening, selectivity and candidate progression.
Center Yourself in Biopharma Dealmaking
Position your brand in front of senior decision-makers by showcasing your company logo across event materials including the website, brochure, event guide and on-site signage.
Demonstrate Your Expertise
Present your capabilities through a dedicated speaking opportunity, panel discussion, bespoke exhibition booth or tailored branding package to demonstrate how your solutions can accelerate RNA-targeted small molecule discovery and development.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from RNA-targeting KOLs on emerging approaches, technical bottlenecks and competitor strategies shaping the future of RNA-targeted therapeutics.
Key Interest Areas
Attendees will be actively seeking cutting-edge solutions across assay development, RNA-focused screening, target engagement, biophysical characterization, RNA sequencing, NGS, NMR, cryo-EM, chemical probing, AI-enabled prediction, computational modelling, medicinal chemistry and preclinical services to advance RNA target selection, strengthen functional validation and accelerate candidate progression.
- Small Molecule Screening Libraries
- Target engagement and fluorescent tagging assays for RNA
- Chemical characterization and synthesis of small molecules
- RNA structural analysis including NMR, Cryo-EM, X-ray crystallography and AI/in-silico modeling
- NGS and HTS RNA sequencing services
- Mass spectrometry and other proteomic techniques
Hear What Our Past Sponsors Have to Say
The RNA conference provides the best opportunity to engage with the largest number of RNA-targeting companies, most of whom attend other conferences but rarely the same ones
Group Leader, Early Discovery Chemistry, PTC Therapeutics
The meeting was very focused and had a very relevant audience. The meeting size made it easy for people to connect and network
Chief Scientific Officer, Arrayjet
It was valuable listening to experts who are actively working on RNA-focused drug discovery and seeing the progress from each company
President & Co-Founder, Lucerna
The smaller size of the event allowed more opportunities for networking and getting to know others better
Principal Scientist, Schrödinger
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Damola Adejuwon
Partnerships Director
Explore the Agenda
Hear the latest industry advances in RNA target selection, structure-guided design, selective modulation and translational strategies across the full RNA-targeted small molecule pipeline and during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Connect with RNA-targeted small molecule leaders across discovery, preclinical and clinical development during our dedicated networking sessions to exchange insights, build collaborations and strengthen decisions from target selection to therapeutic impact.